Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 167

1.

Combined rasagiline and antidepressant use in Parkinson disease in the ADAGIO study: effects on nonmotor symptoms and tolerability.

Smith KM, Eyal E, Weintraub D; ADAGIO Investigators.

JAMA Neurol. 2015 Jan;72(1):88-95. doi: 10.1001/jamaneurol.2014.2472.

PMID:
25420207
2.

Association of UDP-glucuronosyltransferase 1A9 polymorphisms with adverse reactions to catechol-O-methyltransferase inhibitors in Parkinson's disease patients.

Ferrari M, Martignoni E, Blandini F, Riboldazzi G, Bono G, Marino F, Cosentino M.

Eur J Clin Pharmacol. 2012 Nov;68(11):1493-9. doi: 10.1007/s00228-012-1281-y. Epub 2012 Apr 15.

PMID:
22527346
3.

Pisa syndrome in Parkinson's disease: clinical, electromyographic, and radiological characterization.

Tassorelli C, Furnari A, Buscone S, Alfonsi E, Pacchetti C, Zangaglia R, Pichiecchio A, Bastianello S, Lozza A, Allena M, Bolla M, Sandrini G, Nappi G, Martignoni E.

Mov Disord. 2012 Feb;27(2):227-35. doi: 10.1002/mds.23930. Epub 2011 Oct 13.

PMID:
21997192
4.

Cerebrovascular diseases at the C. Mondino National Institute of Neurology: from Ottorino Rossi to the present day.

Micieli G, Martignoni E, Sandrini G, Bono G, Nappi G.

Funct Neurol. 2011 Apr-Jun;26(2):87-95.

5.

Facilitated temporal summation of pain at spinal level in Parkinson's disease.

Perrotta A, Sandrini G, Serrao M, Buscone S, Tassorelli C, Tinazzi M, Zangaglia R, Pacchetti C, Bartolo M, Pierelli F, Martignoni E.

Mov Disord. 2011 Feb 15;26(3):442-8. doi: 10.1002/mds.23458. Epub 2010 Dec 15.

PMID:
21462260
6.

How parkinsonism influences life: the patients' point of view.

Martignoni E, Citterio A, Zangaglia R, Godi L, Pacchetti C, Fundarò C, Corengia E, Bono G, Nappi G.

Neurol Sci. 2011 Feb;32(1):125-31. doi: 10.1007/s10072-010-0435-x. Epub 2010 Nov 6.

PMID:
21057842
7.

Role of 2 common variants of 5HT2A gene in medication overuse headache.

Terrazzino S, Sances G, Balsamo F, Viana M, Monaco F, Bellomo G, Martignoni E, Tassorelli C, Nappi G, Canonico PL, Genazzani AA.

Headache. 2010 Nov;50(10):1587-96. doi: 10.1111/j.1526-4610.2010.01757.x. Epub 2010 Aug 27.

PMID:
20807249
8.

Peripheral expression of key regulatory kinases in Alzheimer's disease and Parkinson's disease.

Armentero MT, Sinforiani E, Ghezzi C, Bazzini E, Levandis G, Ambrosi G, Zangaglia R, Pacchetti C, Cereda C, Cova E, Basso E, Celi D, Martignoni E, Nappi G, Blandini F.

Neurobiol Aging. 2011 Dec;32(12):2142-51. doi: 10.1016/j.neurobiolaging.2010.01.004. Epub 2010 Jan 27.

PMID:
20106550
9.

Clinical experiences with levodopa methylester (melevodopa) in patients with Parkinson disease experiencing motor fluctuations: an open-label observational study.

Zangaglia R, Stocchi F, Sciarretta M, Antonini A, Mancini F, Guidi M, Martignoni E, Pacchetti C.

Clin Neuropharmacol. 2010 Mar-Apr;33(2):61-6. doi: 10.1097/WNF.0b013e3181c5e60c.

PMID:
19935405
10.

A double-blind, delayed-start trial of rasagiline in Parkinson's disease.

Olanow CW, Rascol O, Hauser R, Feigin PD, Jankovic J, Lang A, Langston W, Melamed E, Poewe W, Stocchi F, Tolosa E; ADAGIO Study Investigators.

N Engl J Med. 2009 Sep 24;361(13):1268-78. doi: 10.1056/NEJMoa0809335. Erratum in: N Engl J Med. 2011 May 12;364(19):1882.

11.

An electrophysiological approach to the diagnosis of neurogenic dysphagia: implications for botulinum toxin treatment.

Alfonsi E, Merlo IM, Ponzio M, Montomoli C, Tassorelli C, Biancardi C, Lozza A, Martignoni E.

J Neurol Neurosurg Psychiatry. 2010 Jan;81(1):54-60. doi: 10.1136/jnnp.2009.174698. Epub 2009 Sep 16.

PMID:
19762326
12.

BDNF Val66Met polymorphism is associated with cognitive impairment in Italian patients with Parkinson's disease.

Guerini FR, Beghi E, Riboldazzi G, Zangaglia R, Pianezzola C, Bono G, Casali C, Di Lorenzo C, Agliardi C, Nappi G, Clerici M, Martignoni E.

Eur J Neurol. 2009 Nov;16(11):1240-5. doi: 10.1111/j.1468-1331.2009.02706.x. Epub 2009 Jun 15.

PMID:
19538209
13.

GIGYF2 mutations are not a frequent cause of familial Parkinson's disease.

Di Fonzo A, Fabrizio E, Thomas A, Fincati E, Marconi R, Tinazzi M, Breedveld GJ, Simons EJ, Chien HF, Ferreira JJ, Horstink MW, Abbruzzese G, Borroni B, Cossu G, Dalla Libera A, Fabbrini G, Guidi M, De Mari M, Lopiano L, Martignoni E, Marini P, Onofrj M, Padovani A, Stocchi F, Toni V, Sampaio C, Barbosa ER, Meco G; Italian Parkinson Genetics Network, Oostra BA, Bonifati V.

Parkinsonism Relat Disord. 2009 Nov;15(9):703-5. doi: 10.1016/j.parkreldis.2009.05.001. Epub 2009 May 31.

PMID:
19482505
14.

The role of rehabilitation in deep brain stimulation of the subthalamic nucleus for Parkinson's disease: a pilot study.

Tassorelli C, Buscone S, Sandrini G, Pacchetti C, Furnari A, Zangaglia R, Bartolo M, Nappi G, Martignoni E.

Parkinsonism Relat Disord. 2009 Nov;15(9):675-81. doi: 10.1016/j.parkreldis.2009.03.006. Epub 2009 Apr 26.

PMID:
19398215
15.

Calcium homeostasis is dysregulated in parkinsonian patients with L-DOPA-induced dyskinesias.

Blandini F, Bazzini E, Marino F, Saporiti F, Armentero MT, Pacchetti C, Zangaglia R, Martignoni E, Lecchini S, Nappi G, Cosentino M.

Clin Neuropharmacol. 2009 May-Jun;32(3):133-9. doi: 10.1097/WNF.0B013E3181761466.

PMID:
18978486
16.

Pain as a nonmotor symptom of Parkinson disease: evidence from a case-control study.

Defazio G, Berardelli A, Fabbrini G, Martino D, Fincati E, Fiaschi A, Moretto G, Abbruzzese G, Marchese R, Bonuccelli U, Del Dotto P, Barone P, De Vivo E, Albanese A, Antonini A, Canesi M, Lopiano L, Zibetti M, Nappi G, Martignoni E, Lamberti P, Tinazzi M.

Arch Neurol. 2008 Sep;65(9):1191-4. doi: 10.1001/archneurol.2008.2.

PMID:
18779422
17.

The 6-hydroxydopamine model: news from the past.

Blandini F, Armentero MT, Martignoni E.

Parkinsonism Relat Disord. 2008;14 Suppl 2:S124-9. doi: 10.1016/j.parkreldis.2008.04.015. Epub 2008 Jul 2. Review.

PMID:
18595767
18.

5-hydroxytryptamine1B receptor and triptan response in migraine, lack of association with common polymorphisms.

Velati D, Viana M, Cresta S, Mantegazza P, Testa L, Bettucci D, Rinaldi M, Sances G, Tassorelli C, Nappi G, Canonico PL, Martignoni E, Genazzani AA.

Eur J Pharmacol. 2008 Feb 2;580(1-2):43-7. Epub 2007 Oct 30.

PMID:
18035351
19.

Magnetic resonance spectroscopy in Parkinson's disease and parkinsonian syndromes.

Rango M, Arighi A, Biondetti P, Barberis B, Bonifati C, Blandini F, Pacchetti C, Martignoni E, Bresolin N, Nappi G.

Funct Neurol. 2007 Apr-Jun;22(2):75-9. Review.

PMID:
17637209
20.

[Rehabilitation in Parkinson disease].

Martignoni E, Giordano A, Franchignoni F, Artuso A, Pasetti C, Galante M.

G Ital Med Lav Ergon. 2007 Jan-Mar;29(1):97-100. Review. Italian. No abstract available.

PMID:
17569429
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk